Jump to content

AmpliChip

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Cewbot (talk | contribs) at 01:59, 31 May 2020 (Normalize {{Multiple issues}}: Remove {{Multiple issues}} for only 1 maintenance template(s): More citations needed). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "AmpliChip" – news · newspapers · books · scholar · JSTOR (July 2018) (Learn how and when to remove this message)

AmpliChip is a family of clinical tests from the Swiss healthcare company Hoffmann-La Roche which aim to find out the patients' genotype using micro-array technology. The tests include the CYP450 Test and the P53 Test. The CYP450 Test was approved by the U.S. Food and Drug Administration.^[1]

References

^ "China Approves First Microarray Platform For In Vitro Diagnostic Use". Asian Scientist Magazine | Science, technology and medical news updates from Asia. 2012-02-16. Retrieved 2018-07-25.

Retrieved from "https://en.wikipedia.org/w/index.php?title=AmpliChip&oldid=959883809"

Hidden categories: